Adali Martinez

Adali Martinez

Auto-generated profile, based on publicly available information

Adali Martinez

Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2024 in Academic Pediatrics
Verified
Journal Article
Closed access
AMAdali Martinez
Adali Martinez
MYMorgan Ye
Morgan Ye
DHDanielle Hessler
Danielle Hessler
RRRosemarie de la Rosa
Rosemarie de la Rosa
MBMindy Benson
Mindy Benson
NTNeeta Thakur
Neeta Thakur

1 April 2026 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
MHMollie Hudson
Mollie Hudson
AMAdali Martinez
Adali Martinez
BHBrian Haas
Brian Haas
GSGeorge Su
George Su
BGBrian Graham
Brian Graham
Background: Lung cancer is the leading cause of cancer-related deaths in the United States. Low-dose computed tomography (LDCT) for lung cancer screening (LCS) can reduce lung cancer mortality among patients who meet screening criteria. We conducted a retrospective cohort study to evaluate patient characteristics and eligibility among patients referred by primary care and pulmonary providers for LDCT at a safety net hospital in San Francisco, which does not have a formal LCS program. Methods: We extracted demographic and clinical data from individuals who had undergone LDCT between 2019 and 2023 (n=400), and from individuals referred for evaluation of suspicious pulmonary nodules between 2023 and 2024 (n=20). Results: Of the 400 patients who underwent LDCT, only 47.5% (n=190) had documentation supporting LCS eligibility at the time of chart review. Two lung cancers, both stage 1, were identified in those that met screening criteria; none were diagnosed among those that did not meet screening criteria. Among the 20 patients referred for pulmonary nodule evaluation, 15 met the United States Preventive Services Task Force (USPSTF) criteria for LDCT LCS, but only eight had previously undergone LCS. Conclusions: The absence of a formal LCS program led to high rates of unnecessary screening for lung cancer and underutilization among those that could benefit from it. Of those that met screening criteria, the number needed to screen was 95 to detect one lung cancer, comparable to published data and highlighting the potential utility of an LCS program.

1 May 2023
Verified
Conference Paper
Closed access
MWM. Weingart
M. Weingart
AMA. Martinez
A. Martinez
CBC.A. Berger
C.A. Berger
RWR. Wang
R. Wang